Sun Xueru, Wang Hong, Man XiuYue, Chen Chen, Cong XiaoFeng, Zhang Jing, Yang Lei
Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Front Oncol. 2025 Mar 19;15:1501820. doi: 10.3389/fonc.2025.1501820. eCollection 2025.
This article presents a case study of three patients diagnosed with MiT/TFE tRCC at our hospital. The tumors were located in the left kidney of all three patients, with two of them being under 30 years old. Within a short timeframe, two of all patients developed liver metastases. Genetic testing was conducted in one case, FISH testing in another, and all cases underwent a combination of targeted therapy and immunotherapy. By analyzing the clinical, pathological, and genomic characteristics of these patients, this article aims to enhance the understanding of MiT family translocation renal cell carcinoma, as well as improve the diagnosis, treatment, and prognosis of this rare form of renal cell carcinoma. Further evidence is provided to support these findings.
本文介绍了我院诊断为MiT/TFE易位性肾细胞癌(tRCC)的3例患者的病例研究。所有3例患者的肿瘤均位于左肾,其中2例年龄在30岁以下。在短时间内,所有患者中有2例发生了肝转移。1例进行了基因检测,另1例进行了荧光原位杂交(FISH)检测,所有病例均接受了靶向治疗和免疫治疗的联合治疗。通过分析这些患者的临床、病理和基因组特征,本文旨在加深对MiT家族易位性肾细胞癌的认识,同时改善这种罕见类型肾细胞癌的诊断、治疗和预后。提供了进一步的证据来支持这些发现。